Colinz Laboratories Limited (BOM:531210)
48.04
-1.66 (-3.34%)
At close: Jan 22, 2026
Colinz Laboratories Revenue
Colinz Laboratories had revenue of 13.88M INR in the quarter ending September 30, 2025, a decrease of -25.50%. This brings the company's revenue in the last twelve months to 58.72M, down -15.55% year-over-year. In the fiscal year ending March 31, 2025, Colinz Laboratories had annual revenue of 65.28M, down -7.14%.
Revenue (ttm)
58.72M
Revenue Growth
-15.55%
P/S Ratio
2.06
Revenue / Employee
903.40K
Employees
65
Market Cap
121.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 65.28M | -5.02M | -7.14% |
| Mar 31, 2024 | 70.30M | -1.25M | -1.75% |
| Mar 31, 2023 | 71.55M | 1.81M | 2.59% |
| Mar 31, 2022 | 69.74M | 8.15M | 13.24% |
| Mar 31, 2021 | 61.59M | -14.44M | -19.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 663.49M |
| Sunrest Lifescience | 520.34M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 191.97M |
| Unjha Formulations | 141.50M |
| Zenith Healthcare | 112.08M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |